We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current APDN market cap is 10.05M. The company's latest EPS is USD -0.1382 and P/E is -1.37.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 779k | 891k | 930k | 797k | 813k |
| Operating Income | -4.17M | -3.79M | -3.62M | -3.35M | -3.27M |
| Net Income | -3.49M | -1.11M | -4.7M | 1.88M | -3.3M |
| Year End 30 September 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.93M | 9.03M | 18.17M | 13.37M | 3.43M |
| Operating Income | -12.54M | -13.11M | -13.97M | -10.95M | -14.03M |
| Net Income | -13.03M | -14.29M | -8.27M | -9.95M | -7.23M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 13.65M | 9.91M | 9.18M | 16.69M | 12.79M |
| Total Liabilities | 8.78M | 5.79M | 9.35M | 4.46M | 3.82M |
| Total Equity | 4.87M | 4.13M | -175k | 12.23M | 8.97M |
| Year End 30 September 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 11.34M | 14.42M | 22.27M | 13.65M | 12.79M |
| Total Liabilities | 5.63M | 3.3M | 9.36M | 8.78M | 3.82M |
| Total Equity | 5.71M | 11.11M | 12.91M | 4.87M | 8.97M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -6.22M | -3.76M | -6.97M | -10.46M | -13.71M |
| Investing | -1.1M | N/A | -15k | -37k | -408k |
| Financing | N/A | -35k | 2.98M | 13.79M | 13.4M |
| Year End 30 September 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -11.14M | -13.39M | -8.98M | -6.22M | -13.71M |
| Investing | -1.06M | -2.55M | -490k | -1.1M | -408k |
| Financing | 19.44M | 14.71M | 18.13M | N/A | 13.4M |
| Market Cap | 10.05M |
| Price to Earnings Ratio | -1.37 |
| Price to Sales Ratio | 2.9 |
| Price to Cash Ratio | 1.54 |
| Price to Book Ratio | 1.11 |
| Dividend Yield | - |
| Shares Outstanding | 52.29M |
| Average Volume (1 week) | 2.15M |
| Average Volume (1 Month) | 4.45M |
| 52 Week Change | -98.45% |
| 52 Week High | 14.40 |
| 52 Week Low | 0.1204 |
| Spread (Intraday) | 0 (0.98%) |
| Company Name | Applied DNA Sciences Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.adnas.com |
| Industry | testing laboratories (8734) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
